Skip to main content
OpenTrials

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Bladder Cancer trial results

Completed

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

NCT03924856

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Scripps MD Anderson ( Site 0010) La Jolla, California, United States
  • Providence Saint John's Health Center ( Site 0075) Santa Monica, California, United States
  • Georgetown University Medical Center ( Site 0022) Washington D.C., District of Columbia, United States
  • AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlando ( Site 0005) Orlando, Florida, United States
View all 175 locations
View Trial Details
Completed

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

NCT05512377

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +24 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
View all 60 locations
View Trial Details

Related conditions